In the neighboring state of Connecticut, geographic variation of invasive prostate cancer incidence was large and revealed some consistency before and after the introduction of PSA testing, while the pattern was completely different and variation was much smaller during the years of PSA introduction [28]. This evidence concerns the gene KLK3 and prostate carcinoma.